Mintz Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

At the start of 2022, we reflected on what the Food and Drug Administration (FDA) had accomplished during the preceding 12 months and the challenges that could be ahead for the agency.

Digital health advisory committeeCommerce committeeRadiological healthMintz teamClinical trials transformation initiativeManufacturing technologies designation programHealth care viewpointsDrug administrationHouse energyManufacturing technologyFee reauthorization actDrug omnibus reform actPresident bidenConsolidated appropriations actThrough very tough issuesFederal food